0 XP   0   0   0

Immunicum AB (publ)
Buy, Hold or Sell?

I guess you are interested in Immunicum AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Immunicum AB (publ)

Let's start. I'm going to help you getting a better view of Immunicum AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Immunicum AB (publ) even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Immunicum AB (publ) is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Immunicum AB (publ). The closing price on 2022-09-30 was kr1.858 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Immunicum AB (publ) Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Immunicum AB (publ).

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Immunicum AB (publ) earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Immunicum AB (publ) to the Biotechnology industry mean.
  • A Net Profit Margin of -384.4% means that kr-3.84 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immunicum AB (publ):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-384.4%+384.4%
TTM-384.4%YOY--384.4%
TTM-384.4%5Y-16,876.9%+16,492.5%
5Y-16,876.9%10Y-14,675.5%-2,201.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM-384.4%-275.9%-108.5%
YOY--342.1%+342.1%
5Y-16,876.9%-475.7%-16,401.2%
10Y-14,675.5%-561.7%-14,113.8%
1.1.2. Return on Assets

Shows how efficient Immunicum AB (publ) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Immunicum AB (publ) to the Biotechnology industry mean.
  • -4.1% Return on Assets means that Immunicum AB (publ) generated kr-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immunicum AB (publ):

  • The MRQ is -4.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.3%TTM-4.1%-0.2%
TTM-4.1%YOY-9.3%+5.2%
TTM-4.1%5Y-9.1%+5.0%
5Y-9.1%10Y-10.7%+1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.3%-9.7%+5.4%
TTM-4.1%-8.7%+4.6%
YOY-9.3%-9.2%-0.1%
5Y-9.1%-11.5%+2.4%
10Y-10.7%-12.4%+1.7%
1.1.3. Return on Equity

Shows how efficient Immunicum AB (publ) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Immunicum AB (publ) to the Biotechnology industry mean.
  • -4.9% Return on Equity means the company generated kr-0.05 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immunicum AB (publ):

  • The MRQ is -4.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.9%TTM-4.5%-0.3%
TTM-4.5%YOY-10.0%+5.5%
TTM-4.5%5Y-10.8%+6.2%
5Y-10.8%10Y-12.8%+2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.9%-11.8%+6.9%
TTM-4.5%-11.1%+6.6%
YOY-10.0%-10.6%+0.6%
5Y-10.8%-13.5%+2.7%
10Y-12.8%-14.5%+1.7%

1.2. Operating Efficiency of Immunicum AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Immunicum AB (publ) is operating .

  • Measures how much profit Immunicum AB (publ) makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Immunicum AB (publ) to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immunicum AB (publ):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-375.4%+375.4%
TTM-375.4%YOY--375.4%
TTM-375.4%5Y-16,875.1%+16,499.7%
5Y-16,875.1%10Y-14,674.0%-2,201.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM-375.4%-269.6%-105.8%
YOY--309.3%+309.3%
5Y-16,875.1%-466.7%-16,408.4%
10Y-14,674.0%-572.5%-14,101.5%
1.2.2. Operating Ratio

Measures how efficient Immunicum AB (publ) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are kr0.00for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Immunicum AB (publ):

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.988-3.988
TTM3.988YOY-+3.988
TTM3.9885Y168.798-164.810
5Y168.79810Y146.780+22.017
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM3.9883.542+0.446
YOY-3.491-3.491
5Y168.7985.744+163.054
10Y146.7807.007+139.773

1.3. Liquidity of Immunicum AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Immunicum AB (publ) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 521.5% means the company has kr5.21 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Immunicum AB (publ):

  • The MRQ is 5.215. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.962. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.215TTM6.962-1.747
TTM6.962YOY9.796-2.834
TTM6.9625Y9.519-2.557
5Y9.51910Y9.018+0.501
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2155.266-0.051
TTM6.9626.060+0.902
YOY9.7966.366+3.430
5Y9.5196.692+2.827
10Y9.0186.457+2.561
1.3.2. Quick Ratio

Measures if Immunicum AB (publ) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 95.1% means the company can pay off kr0.95 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immunicum AB (publ):

  • The MRQ is 0.951. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 4.529. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.951TTM4.529-3.578
TTM4.529YOY5.022-0.493
TTM4.5295Y2.005+2.525
5Y2.00510Y1.835+0.169
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9514.055-3.104
TTM4.5294.865-0.336
YOY5.0225.192-0.170
5Y2.0055.275-3.270
10Y1.8354.997-3.162

1.4. Solvency of Immunicum AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Immunicum AB (publ) assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.12 means that Immunicum AB (publ) assets are financed with 12.4% credit (debt) and the remaining percentage (100% - 12.4%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Immunicum AB (publ):

  • The MRQ is 0.124. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.103. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.103+0.021
TTM0.103YOY0.079+0.024
TTM0.1035Y0.111-0.008
5Y0.11110Y0.121-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.271-0.147
TTM0.1030.269-0.166
YOY0.0790.296-0.217
5Y0.1110.361-0.250
10Y0.1210.399-0.278
1.4.2. Debt to Equity Ratio

Measures if Immunicum AB (publ) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 14.2% means that company has kr0.14 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immunicum AB (publ):

  • The MRQ is 0.142. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.116. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.142TTM0.116+0.026
TTM0.116YOY0.086+0.030
TTM0.1165Y0.131-0.015
5Y0.13110Y0.144-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1420.310-0.168
TTM0.1160.311-0.195
YOY0.0860.310-0.224
5Y0.1310.382-0.251
10Y0.1440.438-0.294

2. Market Valuation of Immunicum AB (publ)

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Immunicum AB (publ).

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -3.68 means the investor is paying kr-3.68 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immunicum AB (publ):

  • The EOD is -3.177. Company is losing money. -2
  • The MRQ is -3.676. Company is losing money. -2
  • The TTM is -4.992. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.177MRQ-3.676+0.499
MRQ-3.676TTM-4.992+1.315
TTM-4.992YOY-11.678+6.686
TTM-4.9925Y-7.880+2.888
5Y-7.88010Y-6.852-1.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.177-2.115-1.062
MRQ-3.676-2.332-1.344
TTM-4.992-3.889-1.103
YOY-11.678-5.087-6.591
5Y-7.880-3.697-4.183
10Y-6.852-3.390-3.462
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Immunicum AB (publ).

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Immunicum AB (publ):

  • The MRQ is 0.214. Very good. +2
  • The TTM is 0.119. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.119+0.095
TTM0.119YOY-0.004+0.123
TTM0.1195Y0.255-0.135
5Y0.25510Y0.2550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2140.003+0.211
TTM0.1190.019+0.100
YOY-0.0040.042-0.046
5Y0.2550.020+0.235
10Y0.2550.017+0.238

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Immunicum AB (publ) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.71 means the investor is paying kr0.71 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Immunicum AB (publ):

  • The EOD is 0.617. Very good. +2
  • The MRQ is 0.714. Very good. +2
  • The TTM is 0.964. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.617MRQ0.714-0.097
MRQ0.714TTM0.964-0.249
TTM0.964YOY2.359-1.395
TTM0.9645Y2.504-1.541
5Y2.50410Y2.904-0.400
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6171.843-1.226
MRQ0.7141.961-1.247
TTM0.9642.789-1.825
YOY2.3593.538-1.179
5Y2.5042.782-0.278
10Y2.9042.419+0.485

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Immunicum AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--3.0113.229-7%3.345-10%3.519-14%3.285-8%
Book Value Per Share Growth---0.145-0.145+0%0.316-146%0.038-479%0.137-206%
Current Ratio--5.2156.962-25%9.796-47%9.519-45%9.018-42%
Debt To Asset Ratio--0.1240.103+20%0.079+57%0.111+12%0.121+3%
Debt To Equity Ratio--0.1420.116+22%0.086+65%0.131+8%0.144-2%
Dividend Per Share----0%-0%-0%-0%
Eps---0.147-0.146-1%-0.176+20%-0.294+100%-0.318+116%
Eps Growth---17.151-3.788-78%26.644-164%-16.349-5%-16.349-5%
Gains Per Share---0.145-0.145+0%0.316-146%0.038-479%0.137-206%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----3.8440%-0%-168.7690%-146.7550%
Operating Margin----3.7540%-0%-168.7510%-146.7400%
Operating Ratio---3.988-100%-0%168.798-100%146.780-100%
Pb Ratio0.617-16%0.7140.964-26%2.359-70%2.504-71%2.904-75%
Pe Ratio-3.177+14%-3.676-4.992+36%-11.678+218%-7.880+114%-6.852+86%
Peg Ratio--0.2140.119+79%-0.004+102%0.255-16%0.255-16%
Price Per Share1.858-16%2.1503.146-32%6.904-69%7.110-70%9.104-76%
Quick Ratio--0.9514.529-79%5.022-81%2.005-53%1.835-48%
Return On Assets---0.043-0.041-5%-0.093+117%-0.091+113%-0.107+151%
Return On Equity---0.049-0.045-7%-0.100+105%-0.108+120%-0.128+163%
 EOD+2 -1MRQTTM+5 -11YOY+5 -105Y+7 -910Y+8 -8

3.2. Fundamental Score

Let's check the fundamental score of Immunicum AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.177
Price to Book Ratio (EOD)Between0-10.617
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.951
Current Ratio (MRQ)Greater than15.215
Debt to Asset Ratio (MRQ)Less than10.124
Debt to Equity Ratio (MRQ)Less than10.142
Return on Equity (MRQ)Greater than0.15-0.049
Return on Assets (MRQ)Greater than0.05-0.043
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Immunicum AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.874
Ma 20Greater thanMa 501.931
Ma 50Greater thanMa 1002.165
Ma 100Greater thanMa 2002.204
OpenGreater thanClose1.810
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets685,358
Total Liabilities85,019
Total Stockholder Equity600,339
 As reported
Total Liabilities 85,019
Total Stockholder Equity+ 600,339
Total Assets = 685,358

Assets

Total Assets685,358
Total Current Assets113,853
Long-term Assets113,853
Total Current Assets
Cash And Cash Equivalents 84,855
Net Receivables 20,767
Total Current Assets  (as reported)113,853
Total Current Assets  (calculated)105,622
+/- 8,231
Long-term Assets
Property Plant Equipment 38,455
Goodwill 108,350
Intangible Assets 424,091
Other Assets 609
Long-term Assets  (as reported)571,505
Long-term Assets  (calculated)571,505
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities21,832
Long-term Liabilities63,187
Total Stockholder Equity600,339
Total Current Liabilities
Accounts payable 6,941
Other Current Liabilities 6,858
Total Current Liabilities  (as reported)21,832
Total Current Liabilities  (calculated)13,799
+/- 8,033
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt26,177
Long-term Liabilities Other 39,269
Long-term Liabilities  (as reported)63,187
Long-term Liabilities  (calculated)65,446
+/- 2,259
Total Stockholder Equity
Common Stock9,970
Other Stockholders Equity 3,319
Total Stockholder Equity (as reported)600,339
Total Stockholder Equity (calculated)13,289
+/- 587,050
Other
Capital Stock9,970
Common Stock Shares Outstanding 199,401
Net Invested Capital 600,339
Net Tangible Assets 67,898
Net Working Capital 92,021



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
121,570
102,004
78,615
59,621
246,146
176,360
157,063
138,367
450,373
398,549
370,551
338,875
303,829
268,917
242,131
204,195
728,661
681,986
772,528
744,659
720,984
718,877
685,358
685,358718,877720,984744,659772,528681,986728,661204,195242,131268,917303,829338,875370,551398,549450,373138,367157,063176,360246,14659,62178,615102,004121,570
   > Total Current Assets 
121,429
101,881
78,510
59,533
140,837
176,306
157,024
138,342
450,363
398,548
370,550
338,624
303,577
268,665
241,879
203,943
192,634
145,264
236,073
208,620
185,229
149,829
113,853
113,853149,829185,229208,620236,073145,264192,634203,943241,879268,665303,577338,624370,550398,548450,363138,342157,024176,306140,83759,53378,510101,881121,429
       Cash And Cash Equivalents 
102,899
84,326
61,206
43,586
128,883
168,064
149,971
133,273
443,798
393,359
363,406
334,088
296,811
263,416
232,176
197,603
167,643
118,960
211,709
181,504
155,313
122,926
84,855
84,855122,926155,313181,504211,709118,960167,643197,603232,176263,416296,811334,088363,406393,359443,798133,273149,971168,064128,88343,58661,20684,326102,899
       Short-term Investments 
9,527
9,527
9,527
9,527
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000009,5279,5279,5279,527
       Net Receivables 
2,147
3,446
2,819
2,302
3,500
2,800
2,164
2,092
3,307
3,658
3,043
2,462
2,983
1,652
2,178
1,787
20,230
21,187
17,289
17,479
19,702
18,892
20,767
20,76718,89219,70217,47917,28921,18720,2301,7872,1781,6522,9832,4623,0433,6583,3072,0922,1642,8003,5002,3022,8193,4462,147
       Other Current Assets 
0
0
0
0
7,418
1
0
0
116
0
0
2
1,928
0
1
0
2,843
0
0
1
6,306
0
0
006,3061002,8430101,9282001160017,4180000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
1
1
251
252
252
252
252
536,028
536,723
536,456
536,039
535,754
569,048
571,505
571,505569,048535,754536,039536,456536,723536,02825225225225225111000000000
       Property Plant Equipment 
140
123
105
87
69
53
38
23
9
0
0
0
0
0
0
0
2,909
3,596
3,332
2,898
2,470
35,760
38,455
38,45535,7602,4702,8983,3323,5962,909000000092338536987105123140
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,350
108,350
108,350
108,350
108,350
108,350
108,350
108,350108,350108,350108,350108,350108,350108,3500000000000000000
       Long Term Investments 
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
00000000001111111111111
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
424,091
424,091
424,091
424,091
424,091
424,091
424,091
424,091424,091424,091424,091424,091424,091424,0910000000000000000
       Other Assets 
0
0
0
0
105,239
0
0
1
0
0
0
252
251
251
-1
251
677
685
682
700
844
847
609
609847844700682685677251-1251251252000100105,2390000
> Total Liabilities 
19,184
20,257
16,082
18,747
56,590
15,574
15,632
20,455
44,332
21,648
26,114
24,082
31,048
27,849
27,485
11,793
67,567
62,886
56,436
55,673
64,242
89,620
85,019
85,01989,62064,24255,67356,43662,88667,56711,79327,48527,84931,04824,08226,11421,64844,33220,45515,63215,57456,59018,74716,08220,25719,184
   > Total Current Liabilities 
18,334
19,407
15,232
17,897
55,740
14,723
14,781
19,605
43,482
20,799
25,264
23,232
30,199
26,999
26,635
10,943
48,282
27,500
20,937
19,593
27,576
28,439
21,832
21,83228,43927,57619,59320,93727,50048,28210,94326,63526,99930,19923,23225,26420,79943,48219,60514,78114,72355,74017,89715,23219,40718,334
       Short-term Debt 
850
850
850
850
850
850
850
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000850850850850850850850
       Short Long Term Debt 
850
850
850
850
850
850
850
0
0
0
0
0
0
0
0
0
14,879
0
0
0
0
0
0
00000014,879000000000850850850850850850850
       Accounts payable 
5,041
7,590
4,072
2,623
11,714
2,677
3,489
5,234
31,266
10,369
16,267
10,099
12,819
12,157
20,558
4,867
10,365
11,649
8,824
4,032
11,610
3,810
6,941
6,9413,81011,6104,0328,82411,64910,3654,86720,55812,15712,81910,09916,26710,36931,2665,2343,4892,67711,7142,6234,0727,5905,041
       Other Current Liabilities 
1,044
415
358
331
30,704
1,837
1,226
1,290
838
3,594
1,369
1,384
1,644
1,289
1,385
1,416
769
9,516
6,416
8,940
3,620
3,452
6,858
6,8583,4523,6208,9406,4169,5167691,4161,3851,2891,6441,3841,3693,5948381,2901,2261,83730,7043313584151,044
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
849
850
850
849
850
850
850
19,285
35,386
35,499
36,080
36,666
61,181
63,187
63,18761,18136,66636,08035,49935,38619,285850850850849850850849000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
303
78
0
0
0
0
0
00000783030000000000000000
       Other Liabilities 
0
0
0
0
0
1
1
849
0
-1
0
0
-1
0
0
0
0
1
0
1
0
0
1
1001010000-100-108491100000
> Total Stockholder Equity
102,386
81,747
62,533
40,874
189,556
160,786
141,431
117,912
406,041
376,901
344,437
314,793
272,781
241,068
214,646
192,402
661,094
619,100
716,092
688,986
656,742
629,257
600,339
600,339629,257656,742688,986716,092619,100661,094192,402214,646241,068272,781314,793344,437376,901406,041117,912141,431160,786189,55640,87462,53381,747102,386
   Common Stock
1,298
1,298
1,298
1,298
1,298
2,548
2,548
2,548
3,594
4,613
4,613
4,613
4,613
4,613
4,613
4,613
8,308
8,308
9,970
9,970
9,970
9,970
9,970
9,9709,9709,9709,9709,9708,3088,3084,6134,6134,6134,6134,6134,6134,6133,5942,5482,5482,5481,2981,2981,2981,2981,298
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,003,044
1,003,044
1,130,525
1,130,334
1,130,334
0
0
001,130,3341,130,3341,130,5251,003,0441,003,0440000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
1,250
0
0
1
1,019
0
1
1
1
0
0
0
3,532
3,108
3,082
3,039
3,637
3,327
3,319
3,3193,3273,6373,0393,0823,1083,53200011101,0191001,2500000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-129,277
Operating Income-130,100-129,277
 
Operating Expense (+$)
Research Development85,796
Selling General Administrative43,490
Selling And Marketing Expenses-
Operating Expense129,277129,286
 
Net Interest Income (+$)
Interest Income-3,310
Interest Expense-3,284
Net Interest Income-3,284-6,594
 
Pretax Income (+$)
Operating Income-130,100
Net Interest Income-3,284
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-133,410-130,100
EBIT - interestExpense = -132,561
-133,410
-130,126
Interest Expense3,284
Earnings Before Interest and Taxes (ebit)-129,277-130,126
Earnings Before Interest and Taxes (ebitda)-128,275
 
After tax Income (+$)
Income Before Tax-133,410
Tax Provision-0
Net Income From Continuing Ops-133,410-133,410
Net Income-133,410
Net Income Applicable To Common Shares-133,410
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-3
Total Other Income/Expenses Net-3,284
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
5 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
5 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
5 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
5 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
5 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
5 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
5 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart